Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for prevention of surgical site infection after elective open-heart surgery
IRCT20200507047327N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in surgical site infection (SSI) comparing Rosuvastatin with Placebo (2 arms). Primary endpoint: surgical site infection. Started Oct 2021; status: completed.
02
Drugs
rosuvastatin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20200507047327N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200507047327N2.